CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise  
 
 
 
  Update on HCV  
 
  Target Audience
This activity has been designed to meet the educational needs of gastroenterologists, hepatologists, physician assistants, nurse practitioners involved in the management of chronic liver disease.
 
 
  Educational Objectives
Upon completion of this activity, participants should be better able to:
  • Compare the dosing strategies of telaprevir and boceprevir in treatment naïve HCV patients
  • Compare the dosing strategies of telaprevir and boceprevir in prior pegylated interferon/ribavirin treatment failure patients
  • Define new treatment terminology such as “RGT” and “eRVR”
  • Review SVR rates for the two new agents
 
  Credit Designation
Purdue University School of Pharmacy designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release - April 30, 2011
Expiration - April 30, 2012
*This program has expired. CME credit is no longer available.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Education (ACCME) through the joint sponsorship of Purdue University School of Pharmacy and Focus Medical Communications. Purdue University School of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University School of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Jasmohan Bajaj, MD has received grants/research support from Grifols and Otsuka. He is a Consultant/Speaker Bureau for Grifols, Merz and Otsuka. He is an Honorarium Recipient with Grifols, Merz and Otsuka. He has Editorial Board Involvement with Alimentary Pharmacology and Therapeutics, American Journal of Gastroenterology and Liver International. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. The Focus Medical Communications staff and Purdue University School of Pharmacy staff have no relationships to disclose.

Purdue



Go now

 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of Educational Expertise
Regional Map
Ask the Expert
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.